COLITIS DUE TO CANCER TREATMENT WITH IMMUNE CHECK-POINT INHIBITORS. Radiol Oncol. 2024;58(2):179-185. Accessed July 30, 2026. https://www.ojstest.computing.si/index.php/ro/article/view/4227